AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06345612 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: hypoxia
Description: eccentric training program conducted within normobaric hypoxic chamber
Study NCT06345612 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: normoxia
Description: eccentric training program conducted within normoxic conditions
Study NCT06345612 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: creatine supplementation
Description: 5g of creatine per day
Study NCT06345612 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: no creatine supplementation
Description: no creatine supplementation
Study NCT04860258 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CVnCoV Vaccine
Description: Intramuscular (IM) injection in the deltoid area, preferably in the non-dominant arm.
Study NCT06421090 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Transauricular Vagal Nerve Stimulation
Description: Transauricular vagal nerve stimulation，Intervention group25Hz，Control group1Hz
Study NCT06421090 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Transauricular Vagal Nerve Stimulation
Description: Transauricular vagal nerve stimulation，Intervention group25Hz，Control group1Hz
Study NCT04604236 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mapping Enhanced Counseling
Description: Practitioner-led, collaborative discussion with the youth and their caregiver on co-creating guide maps for decision making around starting treatment and continuing substance use that can help users organize information and think through a series of steps, questions, and behavior choices. encountered when attempting to initiate substance use treatment services. MEC is a communication and decision-making approach that uses graphic visualization tools to train individuals to monitor and control their decision making, improve judgment and behavioral choices (self-regulation), and improve communication and mutual understanding.
Study NCT04604236 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Active Linkage
Description: Practitioner-led, collaborative discussion with the youth and their caregiver on how to overcome barriers encountered when attempting to initiate substance use treatment services. Discussion focuses around the top barriers identified through assessment and identification of 1 or more treatment agency/options that fit the family's needs. Practitioner takes a more active role in addressing barriers to treatment by helping the family find ways to access resources for payment, childcare, or other needs, and actively linking them to the treatment provider (e.g., scheduling the initial appointment with family present).
Study NCT05308225 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: STI-6129
Description: Anti-CD38 A2 human antibody drug conjugate (ADC) containing an antibody covalently bound to a duostatin tubulin inhibitor
Study NCT05458141 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: FYA-003
Description: FYA-003: It is a gamified health education module for children aimed at promoting healthy nutrition, physical activity, health hygiene, and infectious diseases risk reduction within the clinically proven app fooya!
Study NCT06106087 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Mixed methods quality improvement intervention
Description: Quality improvement training for frontline PCH staff
Study NCT05721612 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Flapless transcrestal sinus lift approach with TPRF
Description: Including 8 patients who will be treated by flapless transcrestal sinus floor elevation using the TPRF as a sole grafting material.
Study NCT05721612 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Flapless transcrestal sinus lift approach with PRF
Description: Including 8 patients who will be treated by flapless transcrestal sinus floor elevation using the PRF as a sole grafting material.
Study NCT05315336 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: L-DEP and PD-1 antibody
Description: Doxorubicin (doxorubicin hydrochloride liposome injection) 25 mg/m2 day 1; etoposide 100 mg/m2 was administered day1; methylprednisolone 2mg/kg days 1 to 3,then 0.25mg/kg day 4 to 14; PD-1 antibody injection 200mg day 5; L-asparaginases 6000iu/m2 day2, day4. This regimen was repeated after 2 weeks.
Study NCT05380505 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Racially Congruent Ads
Description: Facebook food ads that are racially congruent.
Study NCT05380505 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Racially Incongruent Ads
Description: Facebook food ads that are racially incongruent.
Study NCT05949125 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide (Non-IMP, Lymphodepletion)
Description: Intravenous infusion over 3 days (d-5 to d-3)
Study NCT05949125 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fludarabine (Non-IMP, Lymphodepletion)
Description: Intravenous infusion over 3 days (d-5 to d-3)
Study NCT05949125 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: R-TM123
Description: Intravenous infusion over 20 days
Study NCT05949125 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Allo-RevCAR01-T
Description: A single dose of Allo-RevCAR01-T will be administered as IV infusion on Treatment day 1. Allo-RevCAR01-T will not be administered again within this study.
Study NCT06354738 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: total hysterectomy with bilateral salpingo-oophorectomy, lymph node staging and comprehensive peritoneal staging
Description: Surgical treatment will consist of total hysterectomy with bilateral salpingo-oophorectomy according to international guidelines.~In low- and intermediate-risk EC patients, staging will include a sentinel lymph node (SLN) procedure. In high intermediate-risk and high-risk EC patients, lymph node staging will involve SLN procedure and/or pelvic and para-aortic lymph node dissection (LND), depending on the local protocol.~The Study-related procedures include infracolic omentectomy or two separate omental representative biopsies, biopsies of all suspicious lesions as well as six peritoneal sites (bladder, pouch of Douglas, bilateral paracolic gutter and bilateral diaphragm).~Stage IV patients will be treated according to European guidelines. When feasible, full surgical intervention (i.e. debulking) is recommended. If this cannot be achieved, a radiologic and/or histologic confirmation of tumor spread beyond the uterus will be accepted.
Study NCT05622188 — intervention group
Intervention type: OTHER
Intervention: Elevated ambient heat
Description: Temporary exposure to increased ambient temperature +10°C (the effect of the intervention is fully and spontaneously reversible)
Study NCT05622188 — intervention group
Intervention type: OTHER
Intervention: Elevated relative humidity
Description: Temporary exposure to increased ambient relative humidity +40% (max. 90%) (the effect of the intervention is fully and spontaneously reversible)
Study NCT05622188 — intervention group
Intervention type: OTHER
Intervention: Exertion
Description: Temporary exertion on an ergometer (1W/kg body weight) (the effect of the intervention is fully and spontaneously reversible)
Study NCT06064786 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: GCF levels of fetuin A and hsCRP evaluation
Description: ELIZA kits are used for GCF levels of fetuin A and hsCRP evaluation
Study NCT04726813 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MyADHD
Description: The main goals of the intervention are to help participants with better functioning in daily life; offer strategies that will lead to stress reduction and reduce inattention and improve quality of life.The intervention includes: a short introductory chapter (open to everyone), followed by a start module (goal setting), followed by 6 different themed optional modules. Module content is based on GMT, DBT and CBT techniques and is tailored towards key concerns and difficulties experienced adults with ADHD as informed by previous research (focus-groups, lived experience groups) and experiences from group GMT and DBT.
Study NCT04726813 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Psychoeducation
Description: Participants in the control condition will be assigned to psychoeducation modules (see Table 2) and will receive restricted access to the platform. They can contact or be contacted if their symptoms levels increases.
Study NCT05154942 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: DOXO+electroacupuncture
Description: DOXO+electroacupuncture
Study NCT04983745 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Combination drug
Description: niraparib and dostarlimab combination
Study NCT05079061 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Misoprostol
Description: sublingual misoprostol 600 micrograms in addition routine uterotonics at third stage of labour
Study NCT05435586 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Web Based Breastfeeding Education and Counseling with Digital Game Support
Description: The educational content prepared by the researcher on the web page will be integrated into the game program designed with the gamification technique. In this designed program, users will be notified at appropriate times to enter the system and play games from the link sent via e-mail. After the users have finished the game, they will fill the scale in the relevant week and will only be able to exit the system in that way.
Study NCT05196243 — intervention group
Intervention type: OTHER
Intervention: Patients diagnosed as gastrointestinal mucosal lesions
Description: Patients diagnosed as gastritis, gastric cancer, intestinal polyps and colorectal cancer
Study NCT05779748 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Single bout of exercise
Description: isometric wall squat at a knee joint angle of 100 degrees. Instruct participant to place their back against the wall with feet positioned parallel and spaced shoulder-width apart. Lower themselves down until they reached a knee joint angle of 100 degrees. Measure knee joint angle by placing a goniometer on the lateral epicondyle of the knee, in line with the femur whilst the anchor arm was in line with the lateral malleolus.
Study NCT06563921 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: physical exercise programme
Description: resistance/hypertrophy-oriented resistance programme
Study NCT06563921 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: physical exercise programme
Description: resistance/hypertrophy-oriented resistance programme
Study NCT06563921 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: probiotics supplementation
Description: probiotics supplementation
Study NCT06563921 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: probiotics supplementation
Description: probiotics supplementation
Study NCT06563921 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: placebo
Study NCT05703399 — intervention group
Intervention type: PROCEDURE
Intervention: Biospecimen Collection
Description: Undergo collection of blood and tissue samples
Study NCT06092242 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tas-102(Suyuan) combined with bevacizumab
Description: Tas-102: po 35 mg/m2, bid, d1-5, d8-12, Q4 wks; bevacizumab: intravenous drip 5 mg/kg, D1, D15, Q4 wks.
Study NCT05703399 — intervention group
Intervention type: OTHER
Intervention: Questionnaire Administration
Description: Complete questionnaire
Study NCT05566418 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: mulligan mobilization
Description: Mulligan mobilization belt will be wrapped around the subject's proximal forearm, close to the elbow joint line, and then wrapped around the therapist's shoulder. This will be done with the therapist's other hand on the distal humerus. The belt will give the subject's forearm a 10-to 15-second lateral glide.
Study NCT05606952 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Color Doppler
Description: color Doppler with pulsed wave Doppler to accurately detect the position of epidural catheter
Study NCT05566418 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: myofascial release
Description: Myofascial release will be performed on the patient, commencing at the common extensor origin and progressing all the way to the extensor retinaculum in the wrist. The periosteum will be engaged with the fingertips, with contact progressing inferiorly to the common extensor tendon and then to the wrist's extensor retinaculum
Study NCT01533623 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Mandibular Advancement Device
Description: Nightly wearing time
Study NCT05305235 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: RISE Guide
Description: Smartphone-based intervention that uses Cognitive Bias Modification to change perceptions of stress.
Study NCT05458531 — intervention group
Intervention type: OTHER
Intervention: Questionnaire
Description: A single questionnaire
Study NCT05458531 — intervention group
Intervention type: OTHER
Intervention: Semi-structured interview
Description: A single semi-structured qualitative interview conducted face-to-face or by telephone or video-conference call.
Study NCT05305235 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Relaxation Control
Description: Guides users through relaxation techniques.
Study NCT06366594 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Authentic leadership training program
Description: 37 first-line nurse managers received authentic leadership training program
Study NCT04856228 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: diagnostic posterior interosseous nerve lidocaine injection
Description: ultrasound guided posterior interosseous nerve and lateral epicondyle 1 ml 2% lidocaine injection
Study NCT04915677 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Soft tissue augmentation with subepithelial connective tissue graft (SCTG)
Description: After local anesthesia a mesio-distal crestal incision will be performed reaching the alveolar bone. Split thickness dissection performed both buccal and palatal. Subepithelial connective tissue graft will be harvested and inserted beneath the mucoperiosteal flap and stretched buccally and lingually using a modified horizontal mattress suture. The flap margins at the crest will be adapted using single interrupted sutures in order to achieve a primary closure of the flap.
Study NCT04915677 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Soft tissue augmentation with xenogenic volume stable collagen matrix
Description: After local anesthesia a mesio-distal crestal incision will be performed reaching the alveolar bone. Split thickness dissection performed both buccal and palatal. Xenogenic volume stable collagen matrix will be inserted beneath the mucoperiosteal flap and stretched buccally and lingually using a modified horizontal mattress suture. The flap margins at the crest will be adapted using single interrupted sutures in order to achieve a primary closure of the flap.
Study NCT06263634 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hand exercises
Description: 30-45 minutes of home exercises consisting of stretching, mobility and strengthening
Study NCT05355415 — intervention group
Intervention type: DEVICE
Intervention: Adaptive optics imaging
Description: Adaptive optics scanning laser ophthalmoscopy (AOSLO) and adaptive optics - optical coherence tomography (AO-OCT) retinal imaging
Study NCT06445101 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Participatory Approach
Description: The participatory approach is a stepwise, collaborative approach to the analysis and solvation of bottlenecks that cause stress in employees.
Study NCT04778202 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: blood sample collection
Description: blood sample collection by venipuncture four both groups and MRI for breast cancr patient group
Study NCT05751109 — intervention group
Intervention type: PROCEDURE
Intervention: ipack+adduktor kanal
Description: nerve block
Study NCT04927702 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Synthetic Hybrid-Scale Fiber Matrix
Description: A synthetic absorbable skin substitute indicated for use in the local management of wounds. It is made of small synthetic fibers that are designed to be similar to the structure of human skin.
Study NCT04927702 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care
Description: To ensure off-loading, each patient will be fitted with an off-loading device based on the investigator's decision, e.g. a boot for forefoot and a heel protector for hindfoot. Patients is instructed on how to care for the surgical site, utilize an off-loading device, and keep the surgical site moist and clean. If the wound is dry, a hydrogel category dressing type should be used. If the wound has exudate, an alginate or foam dressing is recommended.
Study NCT04927702 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Living Cellular Skin Substitute
Description: An absorbable skin substitute comprised of human and bovine (cow) tissues indicated for use in the local management of wounds.
Study NCT05105438 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Consecutive Day Dosing
Description: 100 mg iron as FeSO4 daily for 3 months, followed by matched placebo daily for 3 months.
Study NCT05105438 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Alternate Day Dosing
Description: 100 mg iron as FeSO4 and matched placebo on alternating days for 6 months.
Study NCT06376955 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High intensity interval exercise
Description: HIIT is a type of interval training exercise. It incorporates several rounds that alternate between several minutes of high intensity movements followed by short periods of lower intensity movements 2 times per week for 4 months.
Study NCT06376955 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Focused ultrasound
Description: Focused ultrasound will be applied over the anterior abdominal, two sessions per week for 4 months, each session 40 minutes.
Study NCT06392425 — intervention group
Intervention type: OTHER
Intervention: caspase 3 and ADAM 17 biomarkers
Description: Role of caspase 3 and ADAM 17 biomarkers in chronic kidney disease
Study NCT04820023 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BBT-176
Description: BBT-176 given orally alone
Study NCT06247137 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Dietary Supplement
Description: Dietary supplement formulated with components of natural origin: artichoke, bergamot, folic acid, astaxanthin, Chromium picolinate and excipients.~Oral administration: 1 tablet/day at evening meal
Study NCT06247137 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo (microcrystalline cellulose, calcium carbonate, magnesium stearate, silica dioxide and iron oxides).~Oral administration: 1 tablet/day at evening meal.
Study NCT05120622 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tremelimumab
Description: Tremelimumab 25 mg / 50 mg / 75 mg local cystoscopic injection into bladder wall at or adjacent to site of prior tumour resection (dose divided into 4 injection sites), administered 6 and 3 weeks before radical cystectomy.~Durvalumab 1500mg via IV infusion administered 6 and 3 weeks before radical cystectomy.
Study NCT05909254 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Palatally impacted canine exposure using a surgical guide
Description: Under local anaesthesia the tissues covering the palatally impacted canine are removed with the help of a surgical guide to expose the tooth, to allow the bonding of an attachment on its surface for orthodontic traction.
Study NCT05909254 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Palatally impacted canine exposure using the conventional free.hand method
Description: Under local anaesthesia the tissues covering the palatally impacted canine are removed to expose the tooth, to allow the bonding of an attachment on its surface for orthodontic traction. The surgeon relies on the surgical plan and their experience to localize the impacted canine.
Study NCT05903703 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Canagliflozin and Gemcitabine
Description: on the first, 8th and 15th day of treatment, patients were given intravenous drip of 1000mg/m2 gemcitabine, and 21 days was a course of treatment, lasting for 6 courses.~Take 400mg canagliflozin orally every day, and continue to use it until the end of chemotherapy. According to the patient's tolerance to disulfiram, the dose of canagliflozin can be re-evaluated during the treatment, and the highest dose is 125mg per day. The clinical symptoms, signs and adverse reactions of patients were observed, and the treatment effect of patients was evaluated after two consecutive cycles with 4 weeks as a cycle
Study NCT05903703 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Gemcitabine
Description: on the first, 8th and 15th day of treatment, patients were given 1000mg/m2 gemcitabine intravenously, and 21 days was a course of treatment, lasting for 6 courses.
Study NCT06201728 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Follow-up in a flare-up clinic
Description: Follow-up in the clinic based on the time frame specified above. Additional interventions during the clinic visit, other than specified above, includes: An overview by a pulmonologist of new exacerbations, systemic steroid use, or other hospitalizations, active medications and compliance to treatment, inhaler using technique, possible medication side-effects, and the asthma control test (ACT) score. The physician will provide information on smoking cessation when relevant and pulmonary rehabilitation. In addition, decision on change of treatment and further evaluations outside of the clinic, including initiation of biologic treatment.
Study NCT05775445 — intervention group
Intervention type: PROCEDURE
Intervention: Blood draw
Description: 2 6ml blood tubes will be collected from patient